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http://dx.doi.org/10.1016/j.kjms.201Abstract Remote intrathecal morphine preconditioning (RMPC) induces cardioprotection via a
neural pathway. Intrathecal lidocaine (LID) blocks spinal cord nerve transmission. This study
examine whether LID prevents the effects of RMPC. Anesthetized, open chest, male Sprague-
Dawley ratswereassigned tooneof seven treatment groups 3days after intrathecal catheter place-
ment. Rats from both RMPC and LID groups, respectively, received intrathecal morphine (3 mg/kg)
and lidocaine (1%, 10 mL); morphine was administered by three cycles of 5-minute infusions inter-
spersedwith 5-minute infusion-free periods. The LIDþRMPCgroup received thecombination of LID
and RMPC. Intrathecal naloxone methiodide (NM) (20 mg/kg) was administered either 15 minutes
before RMPC, or 5 minutes before LIDþ RMPC. Ischemia and reperfusion injury were then induced
by30minutesof left coronary artery occlusion, followedby120minutesof reperfusion. Infarct size,
as a percentage of the area at risk (AAR), was determined by 2,3,5-triphenyltetrazolium staining.
The RMPC and LID groups markedly reduced the infarct size (IS) compared with controls. LID pre-
vented the effect of RMPC. NM had no effect on control and LID þ RMPC treatments. However,
NM pretreatment reversed cardioprotection of RMPC treatment. Intrathecal morphine precondi-
tioning is ineffective in the presence of neuraxial blockade with lidocaine.
Copyright ª 2013, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.s have no conflicts of interest relevant to this article.
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right femoral vein was cannulated for saline infusion. Sub-Figure 1. Bar graphs depicting the experimental protocol.
CON Z control; LID Z intrathecal lidocaine (1%, 10 mL);
NM Z intrathecal naloxone methiodide (20 mg/kg);
RMPC Z three cycles of consecutive 5-minute intrathecal
morphine (3  1 mg/kg) infusions interspersed with 5-minute
infusion-free periods.Recently, several studies have shown that intrathecal or
intracerebroventricular administration of morphine confers
remote cardioprotection [1e4]. Lidocaine is one of the
drugs which has been confirmed to be safe in humans and
has the potential to protect the myocardium, not only
against ischemia, but also against reperfusion injury in
animal models [5,6]. However, lidocaine blocks car-
dioprotection produced by ischemic preconditioning [7] or
sevoflurane postconditioning [8] in isolated perfused rat
hearts. Blockade of spinal nerves with epidural anesthesia
could attenuate myocardial apoptosis in acute myocardial
ischemia and infarction in rats [9]. Addition of bupivacaine
to intrathecal opioid could prolong the duration of anal-
gesia [10]. Evidence suggests that bupivacaine potentiates
the binding of morphine to opioid receptors, especially the
highly dense kappa receptors, as the result of an associated
conformational change in opioid receptors [11]. However,
whether spinal blockade could interfere with remote
morphine preconditioning has not been examined. Since
intrathecal morphine, in part, utilizes a neural pathway for
transmission [2], we hypothesized that spinal local anes-
thesia may attenuate this mode of cardioprotection. In this
study, we examine whether intrathecal lidocaine (LID)
prevents cardioprotective effects of remote central
morphine preconditioning in rats.
Materials and methods
This study protocol was approved by our institutional ani-
mal ethics committee and the procedures were conducted
in accordance with the NIH Animal Research Advisory
Committee guidelines. Male Sprague-Dawley rats, weighing
between 280 and 300 g, were used for this study.
Rats were anesthetized by an intraperitoneal injection
of pentobarbitone (50 mg/kg). After sterile preparation of
the posterior neck, a small polyethylene-10 catheter (4 cm)
(Smiths Medical International Ltd, Kent, UK) was inserted
into the thoracic spinal cord through an opening in the
atlanto-occipital membrane as mentioned before [12]. The
wound was closed with deep sutures, followed by cuta-
neous interrupted sutures. After recovery, these animals
were examined for gross motor or sensory deficits. Animals
demonstrating any deficits were excluded from further
experimentation. In addition, Evans blue dye was injected
through the intrathecal catheter to determine catheter
location and any damage to the spinal cord after finishing
the experiment.
Three days after intrathecal catheter placement, the
rats with intrathecal catheters were re-anesthetized by
intraperitoneal administration of pentobarbitone (50 mg/
kg) and maintained by repeat doses of 25 mg/kg every
60e90 minutes as necessary. All of the animals underwent
tracheotomy and tracheal intubation. Mechanical ventila-
tion was provided with a Harvard Apparatus Rodent Respi-
rator (Harvard Apparatus, Boston, MA, USA), and the rats
were ventilated with room air at 70e80 breaths/minute.
Body temperature was monitored and maintained at
37  1C [mean  standard deviation (SD)] using a heating
pad. The right femoral artery was cannulated for directblood pressure monitoring via a pressure transducer and the
cutaneous stainless steel electrodes were connected to a
PowerLab monitoring system (ML750 PowerLab/4sp with
MLT0380 Reusable BP Transducer; AD Instruments, Colorado
Springs, CO, USA) in order to monitor the lead II ECG and
heart rate. A left thoracotomy was performed to expose the
heart at the fifth intercostal space, a 6-0 Prolene loop,
along with a snare occluder, was placed at the origin of the
left coronary artery. Regional ischemia was induced by
pulling the snare and securing the threads with a mosquito
hemostat. Ischemia was confirmed by electrocardiographic
changes, a substantial decrease in mean arterial pressure,
and cardiac cyanosis. Rats were omitted from further data
analysis if severe hypotension (arterial mean blood pressure
<30 mmHg) or intractable ventricular fibrillation occurred.
After surgical preparation, the rats were allowed to stabi-
lize for 15 minutes.
Rats were randomly assigned to receive one of seven
treatments (Fig. 1). All animals were subjected to 30 mi-
nutes of ischemia by occlusion of the left coronary artery,
followed by 2 hours of reperfusion by release of the oc-
clusion: the remote intrathecal morphine preconditioning
(RMPC) and LID groups, respectively, received intrathecal
morphine (3 mg/kg) and lidocaine (1%, 10 mL); morphine was
administered by three cycles of consecutive 5-minute in-
fusions, interspersed with 5-minute infusion-free periods.
This pattern of alternating drug administration with a drug-
free period was done to mimic the pattern of ischemic
preconditioning. The LID þ RMPC group received the com-
bination of LID and RMPC. A nonspecific opioid-receptor
antagonist, naloxone methiodide (NM), which does not
cross the bloodebrain barrier, was used to evaluate the
involvement of opioid receptors of the spinal cord. Intra-
thecal NM (20 mg/kg) [13] was administered either 15 mi-
nutes before RMPC (NM þ RMPC), or 5 minutes before
LID þ RMPC (NM þ LID þ RMPC). Sole administration of NM
intrathecally was also performed to exclude any
70 Y. Lu et al.cardioprotective effect. As negative controls (CON), one
group only received ischemia and reperfusion injury.
The hearts were excised and transferred to a Langen-
dorff apparatus on completion of the reperfusion period
and immediately perfused with normal saline for 1 minute,
at a pressure of 100 cm H2O, to flush out residual blood. The
snare was securely re-tightened and 0.25% Evans blue dye
was injected to stain the normally perfused region of the
heart. This procedure allowed visualization of the normal,
nonischemia region and the area at risk (AAR). The hearts
were then frozen and cut into 2 mm slices. Thereafter, the
slices were stained by incubation at 37C for 20 minutes in
1% 2,3,5-triphenyltetrazolium in phosphate buffer at pH
7.4. This was followed by immersion in 10% formalin for 20
minutes to enhance the contrast of the stain. The areas of
infarct and risk zone for each slice were traced and digi-
tized using a computerized planimetry technique (SigmaS-
can 4.0, Systat Software Inc., Richmond, CA, USA). The
volumes of the left ventricles, infarct size (IS), and AAR
were calculated by multiplying each area with slice thick-
ness and summing the product. The IS was expressed as a
percentage of the AAR (IS/AAR) and this ratio was used to
compare the differences among the groups (Fig. 2).
Data are expressed as mean  standard deviation and
data analysis was performed with a personal computer
statistical software package (Prism v4.0; GraphPad Soft-
ware, San Diego, CA, USA). The hemodynamic data were
analyzed using two-way analysis of variance, with the
Bonferroni correction applied for multiple comparisons if
significant F ratios were obtained. The IS as expressed as
percentage of the AAR (IS/AAR) were analyzed between
groups using one-way analysis of variance, with a Student-
Newman-Keuls post hoc test for multiple comparisons.
Statistical differences were considered significant if the
p value was <0.05.Results
A total of 49 rats were used in the study. Four rats were
excluded because of neurological damage after intrathecal
catheter insertion. A further three did not complete
the ischemia reperfusion protocol, because of severeFigure 2. Non ischemia region Z blue zone; area at rihypotension or ventricular fibrillation. There was one each
from the CON, LID, and LID þ RMPC groups. A total of 42
rats completed the study; all had the correct position of the
intrathecal catheters confirmed at necropsy.
Hemodynamic parameters including heart rate, mean
arterial blood pressure, and rate-pressure product (RPP) at
baseline, after treatment, 30 minutes after left coronary
artery occlusion, and 2 hours after reperfusion, are shown
in Table 1. The MAP and RPP were lowered in groups that
received LID (p < 0.05 vs. CON). There were no significant
differences between each of the groups when compared
with the CON for each time point. As expected, there was a
significant drop of MAP and RPP at 30 minutes of ischemia
and 2 hours of reperfusion in all rats, confirming the suc-
cessful induction of ischemia and reperfusion injury model.
The AAR ranged from 0.41  0.05 cm3 to 0.45  0.04 cm3
and there was no difference in AAR between the control
and treatment groups. As shown in Table 2, the IS/AAR of
CON was 52.8%  5.9%, RMPC and LID markedly reduced IS/
AAR to 27.5%  3.9% and 43.6%  4.9%, respectively
(p < 0.05 vs. CON). LID reversed the effect of RMPC (IS/
AAR: LID þ RMPC, 45.6%  6.0%; p < 0.01 vs. RMPC). NM
(20 mg/kg) had no effect on CON and LID þ RMPC treatment
(IS/AAR: NM, 50.2%  5.5%, p > 0.05 vs. CON;
NM þ LID þ RMPC, 42.9%  7.5%, p > 0.05 vs. LID þ RMPC).
However, NM could reverse the cardioprotective effect
produced by RMPC treatment (IS/AAR: NM þ RMPC,
51.0%  5.6%; p < 0.01 vs. RMPC).Discussion
The results from this study showed that RMPC and LID both
produce a protective effect against myocardial ischemia
and reperfusion injury. However, the combination of RMPC
and LID induced a weaker cardioprotection, not showing
additive effects. NM abolished the protective effect
induced by RMPC, but did not alter the effect of the com-
bination of RMPC and LID. The current results indicate that
LID prevents the cardioprotective effects of RMPC.
Preconditioning with intrathecal or intra-
cerebroventricular administration of morphine has been
shown to protect the heart against ischemia andsk (AAR) Z red zone; infarct size (IS) Z white zone.
Table 1 Hemodynamic parameters in rats for different groups.
Group n Baseline Treatment Ischemia Reperfusion
HR
CON 6 395  24 388  18 358  26 353  22
RMPC 6 401  18 387  12 368  11 349  19
LID 6 394  13 392  14 347  15 349  17
LID þ RMPC 6 390  22 400  11 357  12 362  23
NM þ RMPC 6 387  29 385  14 351  20 339  30
NM þ LID þ RMPC 6 386  41 373  39 339  37 335  31
NM 6 388  26 377  23 351  18 345  25
MAP
CON 6 113  16 104  17 83  14 91  7
RMPC 6 103  17 91  13 74  12 87  6
LID 6 103  17 66  12* 72  9 84  8
LID þ RMPC 6 106  15 71  10* 76  13 88  11
NM þ RMPC 6 100  15 100  20 71  8 82  10
NM þ LID þ RMPC 6 103  23 63  10* 73  11 86  11
NM 6 95  19 93  17 75  8 82  9
RPP
CON 6 45  8 41  8 30  7 32  2
RMPC 6 41  7 35  5 27  4 30  2
LID 6 40  6 26  5* 25  4 29  3
LID þ RMPC 6 41  5 28  4* 27  4 32  5
NM þ RMPC 6 39  6 39  9 25  3 28  4
NM þ LID þ RMPC 6 40  10 23  4* 25  5 29  5
NM 6 37  10 35  9 26  4 29  5
Values are presented as mean  SD. *p < 0.05 versus control (CON).
Baseline Z 15 minutes before surgery; ischemia Z 30 minutes after regional ischemia; reperfusion Z 2 hours after reperfusion.
CONZ control; HRZ heart rate (beats per min); LIDZ intrathecal lidocaine (1%, 10 mL); MAPZ mean arterial blood pressure (mmHg);
NM Z intrathecal naloxone methiodide (20 mg/kg); RPP Z rate-pressure product (mmHg/minute per 1000); RMPC Z three cycles of
consecutive 5-minute intrathecal morphine (3  1 mg/kg) infusions interspersed with 5-minute infusion free periods.
Lidocaine alters remote morphine pretreatment 71reperfusion injury [1e4]. This manifestation of this
myocardial adaption is named as “remote morphine pre-
conditioning” [1,2,4]. We have previously demonstrated
that the activation of spinal opioid receptors by morphine is
an effective means of remotely protecting the heart [3,4].
RMPC similarly can be blocked by hexamethonium, implying
that the signals are conveyed along autonomic fibers, as isTable 2 Morphometrics in rat hearts for different groups.
Group n AAR (cm3) IS/AAR (%)
CON 6 0.41  0.05 52.8  5.9
RMPC 6 0.43  0.02 27.5  3.9*
LID 6 0.42  0.06 43.6  4.9*
LID þ RMPC 6 0.42  0.07 45.6  6.0*,#
NM þ RMPC 6 0.43  0.04 51.0  5.6#
NM þ LID þ RMPC 6 0.45  0.04 42.9  7.5*,#
NM 6 0.43  0.04 50.2  5.5
P 0.932 <0.001
Values are presented as mean  SD. *p < 0.05 versus control
(CON); #p < 0.01 versus RMPC.
AAR Z area at risk; CON Z control; IS Z infarct size;
LID Z intrathecal lidocaine (1%, 10 mL); NM Z intrathecal
naloxone methiodide (20 mg/kg); RMPC Z three cycles of
consecutive 5-minute intrathecal morphine (3  1 mg/kg) in-
fusions interspersed with 5-minute infusion-free periods.the case with remote ischemic preconditioning [2]. The
signals lead to the release of bradykinin and calcitonin gene
related peptide (CGRP) that triggers the cascade of intra-
cellular events that result in the cardioprotective effect [2].
The results from this study confirmed previous findings,
showing that RMPC could induce cardioprotection and opioid
receptors of the spinal cord are involved in this effect.
Lidocaine is often used for the treatment of ventricular
arrhythmias. It has been demonstrated that lidocaine could
protect the heart against ischemia injury [5,6]. Hine et al.
[14] showed that prophylactic lidocaine administration
might increase mortality, due to pump failure or asystole. A
randomized, controlled clinical trial has demonstrated that
the addition of thoracic epidural to conventional general
anesthesia in patients undergoing off-pump coronary artery
bypass graft surgery, accounts for a significant reduction in
the incidence of postoperative arrhythmias and improve-
ment in overall quality of recovery [15]. LID prevents car-
diovascular collapse in a rat model of acute intracranial
hypertension [16]. It was reported that thoracic epidural
anesthesia could reduce myocardial infarcted size after
coronary artery occlusion in dogs [17]. Blockade of spinal
nerves could result in the reduction of peripheral resistance
of circulation, which may help to improve coronary circu-
lation and attenuate myocardial apoptosis in acute
myocardial ischemia and infarction in rats [9]. In this study,
we showed that LID also could produce a protective effect.
72 Y. Lu et al.The opening of KATP channels has been shown to be an
important component of preconditioning, which is the most
potent mechanism of protection against myocardial
ischemia and reperfusion injury [18]. Thus, ischemic pre-
conditioning and RMPC may share the opening of KATP
channels during cardioprotection [2]. Olschewski et al. [19]
found that lidocaine blocked the KATP channel of rat car-
diomyocytes. This probably is the main reason why lido-
caine prevents the effects of ischemic preconditioning or
sevoflurane postconditioning [7,8].
Interestingly, in this study we observed the preservation
of the weaker cardioprotective effect of RMPC, despite the
administration of lidocaine. NM did not abolish the effect of
the combination of RMPC and lidocaine. This suggests that
opioid receptors are not involved in this effect, and that LID
prevents activation of spinal cord opioid receptors induced
by RMPC.
There are several limitations to this study. First, we did
not explain that the specific mechanism underlining the
effect of LID prevents the cardioprotective effects of
RMPC. Second, lidocaine could cancel cardioprotection
produced by ischemic preconditioning in isolated perfused
rat hearts [7]. Intrathecal morphine remotely preconditions
the heart via a neural pathway [2]. Therefore, we did not
show if intravenous lidocaine prevents the effects induced
by RMPC in this study. Lastly, whether a higher dose of NM
could also abolish the poorer cardioprotective effects of
the combination of RMPC and LID was not examined in this
study and remains to be demonstrated.
In summary, our findings have demonstrated that LID and
intrathecal remote morphine preconditioning both produce
protective effects against myocardial ischemia and reper-
fusion injury in rats. It was further shown that intrathecal
morphine preconditioning is ineffective in the presence of
neuraxial blockade with lidocaine. These findings strongly
remind us that the postoperative analgesia model of
simultaneously administered local anesthetic with opioids
intrathecally should be cautiously used in patients with
ischemia heart disease undergoing surgery.Acknowledgments
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